Product NDC: | 0006-0705 |
Proprietary Name: | NOROXIN |
Non Proprietary Name: | Norfloxacin |
Active Ingredient(s): | 400 mg/1 & nbsp; Norfloxacin |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0006-0705 |
Labeler Name: | Merck Sharp & Dohme Corp. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA019384 |
Marketing Category: | NDA |
Start Marketing Date: | 19861031 |
Package NDC: | 0006-0705-20 |
Package Description: | 20 TABLET, FILM COATED in 1 BOTTLE (0006-0705-20) |
NDC Code | 0006-0705-20 |
Proprietary Name | NOROXIN |
Package Description | 20 TABLET, FILM COATED in 1 BOTTLE (0006-0705-20) |
Product NDC | 0006-0705 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Norfloxacin |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 19861031 |
Marketing Category Name | NDA |
Labeler Name | Merck Sharp & Dohme Corp. |
Substance Name | NORFLOXACIN |
Strength Number | 400 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Quinolone Antimicrobial [EPC],Quinolones [Chemical/Ingredient] |